OVERVIEW

Advances in Multi-Disciplinary Head and Neck Cancer Care is organized by University of California San Francisco (UCSF) and will be held from Sep 12 - 14, 2024 at Grand Hyatt San Francisco, San Francisco, California, United States of America.

Overview:
This course is designed for head and neck cancer providers representing the entire multidisciplinary team. This includes head and neck cancer surgeons, medical oncologists, radiation oncologists, dietitians, nurses, social workers and speech-language pathologists. The course will offer a blend of didactic and interactive experiences highlighting state-of-the-art head and neck cancer care from evaluation and treatment to survivorship. Renowned faculty members from both institutions will share the most up-to-date information regarding scientific advancements and novel approaches to optimize both curative and functional outcomes in the head and neck cancer population.

Learning Objectives:
We specifically anticipate improvements in skills and strategies to:

  • Implement best practice in the complex, multidisciplinary delivery of care for head and neck cancer patients;
  • Discuss updates in the management of oral cavity, oropharynx, and larynx cancer;
  • Optimize the use of pathology and radiology to guide head and neck, thyroid, and salivary cancer management;
  • Evaluate the goals and techniques of head and neck reconstruction with a focus on functional outcomes;
  • Incorporate novel innovations in diagnostic and therapeutic approaches in patient care;
  • Determine appropriate evaluations for dysphagia, voice, communication and trismus for patient with head and neck cancer;
  • Identify swallowing therapy techniques appropriate to optimize swallowing/voice outcomes for patients with head and neck cancer;
  • Provide rationale for the necessity of instrumental swallowing assessment in patients with head and neck cancer.

KEY DATES

Event Start Date
12 Sep, 2024
Event Start Date
Event End Date
14 Sep, 2024
Event End Date
Credits

Accreditation:
In support of improving patient care, this activity has been planned and implemented by UCSF and UCSD. University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
UCSF designates this live activity for a maximum of 16.50 AMA PRA Category 1 CreditsTM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity meets the requirements under California Assembly, Bill 1195, continuing education and cultural and linguistic competency.

Speech Language Pathologists
The University of California, San Francisco is a Speech-Language Pathology and Audiology and Hearing Aid Dispensers Board (SLPAHADB) approved provider for continuing professional development courses. This live activity meets the qualifications for 16.50 hours of continuing professional development credit for speech language pathologists as required by SLPAHADB. Provider Number: PDP453

Nurses
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditsTM issued by organizations accredited by the ACCME.

Physician Assistants
AAPA accepts category 1 credit from AOACCME, prescribed credit from AAFP, and AMA PRA Category 1 CreditsTM  from organizations accredited by the ACCME.

Pharmacists
The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 CreditsTM

American Board of Otolaryngology – Head and Neck Surgery MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of recognizing participation. 

  • 16.5 AMA PRA Category 1 Credits™
  • 16.5 Hours
  • TARGET AUDIENCE

    PhysicianPharmacistPhysician AssistantSurgeonsOncologistsNursesDietitianSocial WorkersSpeech Language PathologistsOral and Maxillofacial SurgeonsRadiation OncologistsMedical OncologistsTrainees

    SPECIALITIES

    OncologyOral and Maxillofacial Surgery

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationGrand Hyatt San Francisco
    345 Stockton St

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235